Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 549054, 9 pages
http://dx.doi.org/10.1155/2014/549054
Research Article

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell

1Department of Internal Medicine, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, Republic of Korea
2Department of Pathology, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Republic of Korea
3Department of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, Grand Rapids, MI 49530, USA

Received 4 September 2014; Revised 25 November 2014; Accepted 25 November 2014; Published 10 December 2014

Academic Editor: Giuseppe Murdaca

Copyright © 2014 Ju Hee Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. D. Dangas, B. E. Claessen, A. Caixeta, E. A. Sanidas, G. S. Mintz, and R. Mehran, “In-stent restenosis in the drug-eluting stent era,” Journal of the American College of Cardiology, vol. 56, no. 23, pp. 1897–1907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Libby, P. M. Ridker, and G. K. Hansson, “Progress and challenges in translating the biology of atherosclerosis,” Nature, vol. 473, no. 7347, pp. 317–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Pauletto, S. Sartore, and A. C. Pessina, “Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis,” Clinical Science, vol. 87, no. 5, pp. 467–479, 1994. View at Google Scholar · View at Scopus
  4. C. Bauters and J. M. Isner, “The biology of restenosis,” Progress in Cardiovascular Diseases, vol. 40, no. 2, pp. 107–116, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. W. S. Weintraub, “The pathophysiology and burden of restenosis,” The American Journal of Cardiology, vol. 100, no. 5, pp. S3–S9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Ip, V. Fuster, L. Badimon, J. Badimon, M. B. Taubman, and J. H. Chesebro, “Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation,” Journal of the American College of Cardiology, vol. 15, no. 7, pp. 1667–1687, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Casscells, “Migration of smooth muscle and endothelial cells: critical events in restenosis,” Circulation, vol. 86, no. 3, pp. 723–729, 1992. View at Publisher · View at Google Scholar · View at Scopus
  8. A. K. Mitra and D. K. Agrawal, “In stent restenosis: bane of the stent era,” Journal of Clinical Pathology, vol. 59, no. 3, pp. 232–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Makkinje, D. A. Quinn, A. Chen et al., “Gene 33/mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress,” The Journal of Biological Chemistry, vol. 275, no. 23, pp. 17838–17847, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Fiorentino, C. Pertica, M. Fiorini et al., “Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain,” Molecular and Cellular Biology, vol. 20, no. 20, pp. 7735–7750, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Tsunoda, J. Inokuchi, I. Baba et al., “A novel mechanism of nuclear factor κB activation through the binding between inhibitor of nuclear factor-κBα and the processed NH2-terminal region of Mig-6,” Cancer Research, vol. 62, no. 20, pp. 5668–5671, 2002. View at Google Scholar · View at Scopus
  12. Y.-W. Zhang and G. F. V. Woude, “Mig-6, signal transduction, stress response and cancer,” Cell Cycle, vol. 6, no. 5, pp. 507–513, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Anastasi, L. Fiorentino, M. Fiorini et al., “Feedback inhibition by RALT controls signal output by the ErbB network,” Oncogene, vol. 22, no. 27, pp. 4221–4234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Xu, A. Makkinje, and J. M. Kyriakis, “Gene 33 is an endogenous inhibitor of Epidermal Growth Factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function,” The Journal of Biological Chemistry, vol. 280, no. 4, pp. 2924–2933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Zhang, K. A. Pickin, R. Bose, N. Jura, P. A. Cole, and J. Kuriyan, “Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface,” Nature, vol. 450, no. 7170, pp. 741–744, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-W. Zhang, B. Staal, Y. Su et al., “Evidence that MIG-6 is a tumor-suppressor gene,” Oncogene, vol. 26, no. 2, pp. 269–276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Anastasi, G. Sala, C. Huiping et al., “Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin,” Oncogene, vol. 24, no. 28, pp. 4540–4548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Ferby, M. Reschke, O. Kudlacek et al., “Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation,” Nature Medicine, vol. 12, no. 5, pp. 568–573, 2006. View at Google Scholar · View at Scopus
  19. T. H. Kim, H. L. Franco, S. Y. Jung et al., “The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression,” Oncogene, vol. 29, no. 26, pp. 3770–3780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-I. Lin, J. Du, W. T. Shen et al., “Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 3, pp. E554–E565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. H. Kim, D.-K. Lee, S.-N. Cho et al., “Critical tumor suppressor function mediated by epithelial mig-6 in endometrial cancer,” Cancer Research, vol. 73, no. 16, pp. 5090–5099, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. B. J. Ku, T. H. Kim, J. H. Lee et al., “Mig-6 plays a critical role in the regulation of cholesterol homeostasis and bile acid synthesis,” PLoS ONE, vol. 7, no. 8, Article ID e42915, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Tomita, Y. Hirata, M. Uchihashi, and T. Fujita, “Characterization of epidermal growth factor receptors in cultured vascular smooth muscle cells of rat aorta,” Endocrinologia Japonica, vol. 33, no. 2, pp. 177–184, 1986. View at Publisher · View at Google Scholar · View at Scopus
  24. L. B. Nanney, C. M. Stoscheck, and L. E. King, “Characterization of binding and receptors for epidermal growth factor in smooth muscle,” Cell and Tissue Research, vol. 254, no. 1, pp. 125–132, 1988. View at Google Scholar · View at Scopus
  25. D. Gospodarowicz, K. Hirabayashi, L. Giguere, and J. P. Tauber, “Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture,” The Journal of Cell Biology, vol. 89, no. 3, pp. 568–578, 1981. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Thyberg, U. Hedin, M. Sjolund, L. Palmberg, and B. A. Bottger, “Regulation of differentiated properties and proliferation of arterial smooth muscle cells,” Arteriosclerosis, vol. 10, no. 6, pp. 966–990, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Higashiyama, J. A. Abraham, and M. Klagsbrun, “Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate,” The Journal of Cell Biology, vol. 122, no. 4, pp. 933–940, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Jin, J. L. Gilbert, R. R. Broaddus, F. J. Demayo, and J.-W. Jeong, “Generation of a Mig-6 conditional null allele,” Genesis, vol. 45, no. 11, pp. 716–721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Anastasi, M. F. Baietti, Y. Frosi, S. Alemà, and O. Segatto, “The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity,” Oncogene, vol. 26, no. 57, pp. 7833–7846, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Higuchi, H. Ohtsu, H. Suzuki, H. Shirai, G. D. Frank, and S. Eguchi, “Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology,” Clinical Science, vol. 112, no. 7-8, pp. 417–428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Eguchi, K. Numaguchi, H. Iwasaki et al., “Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein/kinase activation in vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 273, no. 15, pp. 8890–8896, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Kodali, M. Hajjou, A. B. Berman et al., “Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells,” Cardiovascular Research, vol. 69, no. 3, pp. 706–715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Makki, K. W. Thiel, and F. J. Miller Jr., “The epidermal growth factor receptor and its ligands in cardiovascular disease,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 20597–20613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Schreier, M. Döhler, S. Rabe et al., “Consequences of epidermal growth factor receptor (ErbB1) loss for vascular smooth muscle cells from mice with targeted deletion of ErbB1,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 7, pp. 1643–1652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Han, C. G. Caday, A. Nanda, W. K. Cavenee, and H.-J. S. Huang, “Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors,” Cancer Research, vol. 56, no. 17, pp. 3859–3861, 1996. View at Google Scholar · View at Scopus
  36. G. Partik, K. Hochegger, M. Schörkhuber, and B. Marian, “Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro,” Journal of Cancer Research and Clinical Oncology, vol. 125, no. 7, pp. 379–388, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Shushan, N. Rojansky, N. Laufer et al., “The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth,” Human Reproduction, vol. 19, no. 9, pp. 1957–1967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. Y.-G. Zhang, Q. Du, W.-G. Fang, M.-L. Jin, and X.-X. Tian, “Tyrphostin AG1478 supresses proliferation and invasion of human breast cancer cells,” International Journal of Oncology, vol. 33, no. 3, pp. 595–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Eguchi, K. Numaguchi, H. Iwasaki et al., “Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein/kinase activation in vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 273, no. 15, pp. 8890–8896, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Iwasaki, S. Eguchi, F. Marumo, and Y. Hirata, “Endothelin-1 stimulates DNA synthesis of vascular smooth-muscle cells through transactivation of epidermal growth factor receptor,” Journal of Cardiovascular Pharmacology, vol. 31, no. 1, pp. S182–S184, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Bokemeyer, U. Schmitz, and H. J. Kramer, “Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor,” Kidney International, vol. 58, no. 2, pp. 549–558, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Tamura, J.-I. Miyagawa, M. Nishida et al., “Immunohistochemical localization of Betacellulin, a member of epidermal growth factor family, in atherosclerotic plaques of human aorta,” Atherosclerosis, vol. 155, no. 2, pp. 413–423, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Takahashi, K. Hayashi, K. Yoshida et al., “Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells,” Circulation, vol. 108, no. 20, pp. 2524–2529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. A. K. Chan, A. Kalmes, S. Hawkins, G. Daum, and A. W. Clowes, “Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery,” Journal of Vascular Surgery, vol. 37, no. 3, pp. 644–649, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Shafi, D. Lamb, H. Modjtahedi, and G. Ferns, “Periadventitial delivery of anti-EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit,” International Journal of Experimental Pathology, vol. 91, no. 3, pp. 224–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Hopkins, E. Linderoth, O. Hantschel et al., “Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis,” Developmental Cell, vol. 23, no. 3, pp. 547–559, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J.-W. Jeong, S. L. Hee, K. Y. Lee et al., “Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8677–8682, 2009. View at Publisher · View at Google Scholar · View at Scopus